Ying L Liu, Sushmita Gordhandas, Kanika Arora, Eric Rios-Doria, Karen A Cadoo, Amanda Catchings, Anna Maio, Yelena Kemel, Margaret Sheehan, Erin Salo-Mullen, Qin Zhou, Alexia Iasonos, Jian Carrot-Zhang, Beryl Manning-Geist, Tiffany Y Sia, Pier Selenica, Chad Vanderbilt, Maksym Misyura, Alicia Latham, Chaitanya Bandlamudi, Michael F Berger, Jada G Hamilton, Vicky Makker, Nadeem R Abu-Rustum, Lora H Ellenson, Kenneth Offit, Diana L Mandelker, Zsofia Stadler, Britta Weigelt, Carol Aghajanian, Carol Brown
BACKGROUND: Racial disparities in outcomes exist in endometrial cancer (EC). The contribution of ancestry-based variations in germline pathogenic variants (gPVs) is unknown. METHODS: Germline assessment of ≥76 cancer predisposition genes was performed in patients with EC undergoing tumor-normal Memorial Sloan Kettering Cancer Center Integrated Mutation Profiling of Actionable Cancer Targets sequencing from January 1, 2015 through June 30, 2021. Self-reported race/ethnicity and Ashkenazi Jewish ancestry data classified patients into groups...
October 27, 2023: Cancer